Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Major bleeding in patients with atrial fibrillation treated with apixaban versus warfarin in combination with amiodarone: nationwide cohort study

Background Amiodarone is an established treatment for atrial fibrillation (AF) but might interfere with the metabolism of apixaban or warfarin. Therefore, the aim was to investigate the occurrence of major bleeding among patients with AF treated with amiodarone in combination with apixaban or warfar...

Full description

Bibliographic Details
Main Authors:	Christina Christersson, Gorav Batra, Claes Held, Henrik Renlund, Angelo Modica, Astrid Fritz Hansson
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/11/1/e002555.full

Similar Items

Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease
by: Anders Larsson, et al.
Published: (2022-08-01)

Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation
by: Johan Westerbergh, et al.
Published: (2024-01-01)

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non–Vitamin K Oral Anticoagulants Across Varying Body Mass Index
by: Astrid Fritz Hansson, et al.
Published: (2023-11-01)

Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.
by: Christina Christersson, et al.
Published: (2022-01-01)

Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation.
by: Sutee Limcharoen, et al.
Published: (2024-01-01)

Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
by: Chung-Ming Fu, et al.
Published: (2021-10-01)

Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation.
by: Soyon Lee, et al.
Published: (2012-01-01)

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.
by: Lars J Kjerpeseth, et al.
Published: (2019-01-01)

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
by: Yi‐Hsin Chan, et al.
Published: (2018-04-01)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
by: Brandon K. Martinez, et al.
Published: (2018-04-01)

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study
by: Koretsune Y, et al.
Published: (2017-12-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation
by: Yutaro Mukai, et al.
Published: (2017-10-01)

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
by: Matthew A. Wanat, et al.
Published: (2019-10-01)

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
by: Gregory Y H Lip, et al.
Published: (2018-01-01)

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial
by: Peter T. Hu, et al.
Published: (2017-01-01)

Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
by: Yosuke Miwa, et al.
Published: (2016-06-01)

Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation
by: Andrew Martin, et al.
Published: (2012-01-01)

Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation
by: Andrew Martin, et al.
Published: (2012-07-01)

Cost-Effectiveness of Apixaban versus Warfarin in Chinese Patients with Non-Valvular Atrial Fibrillation: A Real-Life and Modelling Analyses.
by: Xue Li, et al.
Published: (2016-01-01)

Conversion of atrial fibrillation to sinus rhythm with amiodarone.
by: A. Lema Santos, et al.
Published: (2022-01-01)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding.
by: Alexander T Cohen, et al.
Published: (2022-01-01)

Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation
by: Sutee Limcharoen, et al.
Published: (2022-08-01)

Clinical experience with apixaban in atrial fibrillation: implications of AVERROES
by: De Caterina R
Published: (2011-07-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

The use of warfarin in veterans with atrial fibrillation
by: Rosenbeck Karen, et al.
Published: (2004-10-01)

In response to "Anaphylaxis during intravenous administration of amiodarone" Is amiodarone the best choice for management of atrial fibrillation?
by: Indira Malik
Published: (2014-01-01)

Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes
by: Chieh Tsai, et al.
Published: (2017-10-01)

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
by: Ioannou A, et al.
Published: (2017-11-01)

Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights
by: Markus Gulilat, PhD, et al.
Published: (2022-01-01)

Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
by: Hallinen T, et al.
Published: (2021-08-01)

Amiodarone prevention for atrial fibrillation relapse after surgical ablation
by: Ivayla Zheleva-Kyuchukova, et al.
Published: (2023-09-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
by: Abolfath Alizadeh, et al.
Published: (2022-01-01)

"Efficacy of Propranolol and Amiodarone on Prevention of Atrial Fibrillation after CABG "
by: S.K Forouzan-nia, et al.
Published: (2006-08-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE
by: O. O. Shakhmatova, et al.
Published: (2017-05-01)